Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaHemp is a Slovenia-based private company focused on hemp-derived cannabinoid products for wellness, cosmetics, food supplements, oral care, and pet care. The company operates consumer and B2B businesses, selling branded CBD products while also offering raw materials, custom formulations, private-label manufacturing, filling services, analytical laboratory testing, and regulatory support. Its portfolio includes CBD oils, pastes, capsules, creams, skincare, oral care, and pet products, as well as bulk cannabinoid ingredients such as CBD, CBN, CBG, CBDA, and CBGA in full-spectrum, broad-spectrum, and isolate-based formats. PharmaHemp manufactures in Slovenia and states that its products are distributed in more than 70 countries. The company appears to be a commercial cannabinoid wellness and manufacturing business rather than a therapeutics-focused biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaHemp.